Mahamaya Lifesciences Outlines Strategic Growth, Financial Expansion, and Dahej Facility Roadmap
Mahamaya Lifesciences Ltd · Others (Uncategorized) · 09 Oct 2026, 11:15 pm
Mahamaya Lifesciences Outlines Strategic Growth, Financial Expansion, and Dahej Facility Roadmap Mahamaya Lifesciences reported robust FY'25–'26 performance, with revenue up 24.5% YoY to Rs. 328.87 crore, EBITDA rising 32.6% YoY to Rs. 34.26 crore, and PAT surging 29.0% YoY to Rs. 16.52 crore. Net debt-to-equity improved to 0.74x from 1.18x. The company is deploying IPO proceeds toward backward integration at Dahej, Gujarat, targeting formulation expansion and pilot operations by Dec'26, followed by commercial technical production in 2027. Strategic focus includes expanding proprietary branded products, high-margin bio-fermented solutions, and overseas registrations across LatAm, Middle East, and Africa.
Original exchange filing (PDF)
More announcements from Mahamaya Lifesciences Ltd
- Mahamaya Lifesciences Limited has informed the Exchange about Schedule of Meet to be held on Thursday, November 19, 2026 at 04.00 PM · 19 Nov 2026
- Submission of Monitoring Agency Report for the half year ended September 30, 2026 · 13 Nov 2026
- Financial Results for the half year ended September 30, 2026 · 13 Nov 2026
- Outcome of Board meeting held on Today i.e. November 13, 2026 · 13 Nov 2026
- Mahamaya Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve unaudited financials .... · 13 Nov 2026
- Submission of Non-Applicability of Compliance of Corporate Governance as required under Regulation 27(2) of SEBI (LODR) Regulations, 2015 · 29 Oct 2026
- Appointment of Dr. Bhagirath Choudhary as Independent Director, Re-appointment of Dr. Charudatta Digambar Mayee as Independent Director, Re-appointment of Mr. Gopal Krishna Raju as Independent .... · 30 Sept 2026
- Mahamaya Lifesciences Limited has informed the exchange regarding the voting results and scrutinizer report of the 24th Annual General Meeting held on September 29, 2026 · 30 Sept 2026
